R. Nuti

Publications386
h-index40
Citations6,457
Highly Influential Citations247
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • C. O'Connor
  • 1,108 Publications, 59,319 Citations
  • L. Gennari
  • 141 Publications, 4,773 Citations
  • A. Voors
  • 777 Publications, 39,466 Citations
  • D. Merlotti
  • 119 Publications, 2,462 Citations
  • Publications
  • Influence
Genetics of osteoporosis
  • 387
  • 20
Prevalence of Paget's Disease of Bone in Italy
We examined the prevalence of PDB in Italy from radiological, scintigraphic, and biochemical surveys in two Italian towns. Prevalence rates varied from 0.7% to 2.4%, were higher in males than in… Expand
  • 82
  • 8
Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study
SummaryThis study aimed to evaluate the prevalence of vertebral fractures to investigate the determinants of vertebral fracture risk in patients with COPD. The risk of vertebral fractures is strictly… Expand
  • 96
  • 7
Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men.
Male osteoporosis is an increasingly important health problem. It is known that sex steroid hormones play an important role in regulating bone turnover and bone mass in males as well as in females.… Expand
  • 222
  • 6
Aromatase activity and bone homeostasis in men.
It is known that sex steroid hormones play an important role in the maintenance of bone mass in males as well as in females. Even though androgens are the major sex steroids in men, their primacy in… Expand
  • 150
  • 6
Mechanisms of impaired bone strength in type 1 and 2 diabetes.
Diabetes and osteoporosis are common and complex disorders with an enormous health burden that can be often associated especially in middle-age and elderly individuals. Although there is raising… Expand
  • 84
  • 6
Endocrine Actions of Osteocalcin
Osteocalcin is the most abundant noncollagenous protein of bone matrix. Once transcribed, this protein undergoes posttranslational modifications within osteoblastic cells before its secretion,… Expand
  • 97
  • 6
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.
CONTEXT Previous observations showed a condition of low bone turnover and decreased osteoblast activity in both type 1 and 2 diabetes mellitus (DM1 and DM2). Sclerostin is a secreted Wnt antagonist… Expand
  • 107
  • 5
SQSTM1 gene analysis and gene‐environment interaction in Paget's disease of bone
Even though SQSTM1 gene mutations have been identified in a consistent number of patients, the etiology of Paget's disease of bone (PDB) remains in part unknown. In this study we analyzed SQSTM1… Expand
  • 60
  • 5
Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
BACKGROUND Although anemia is frequently found in congestive heart failure (CHF), little is known about the effect of its correction with erythropoietin (EPO) on cardiac structure and function. … Expand
  • 132
  • 4